20,876 Shares in Alignment Healthcare, Inc. (NASDAQ:ALHC) Acquired by Stephens Inc. AR

Stephens Inc. AR bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 20,876 shares of the company's stock, valued at approximately $389,000.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. increased its stake in Alignment Healthcare by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 9,818,071 shares of the company's stock valued at $110,453,000 after buying an additional 166,837 shares during the period. T. Rowe Price Investment Management Inc. increased its stake in Alignment Healthcare by 54.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock valued at $97,302,000 after buying an additional 3,059,596 shares during the period. Wellington Management Group LLP increased its stake in Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock valued at $83,683,000 after buying an additional 3,257,630 shares during the period. Hood River Capital Management LLC increased its stake in Alignment Healthcare by 39.6% in the 4th quarter. Hood River Capital Management LLC now owns 4,952,995 shares of the company's stock valued at $55,721,000 after buying an additional 1,405,212 shares during the period. Finally, 8 Knots Management LLC increased its stake in Alignment Healthcare by 49.5% in the 4th quarter. 8 Knots Management LLC now owns 3,658,695 shares of the company's stock valued at $41,160,000 after buying an additional 1,211,727 shares during the period. 86.19% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $14.48, for a total transaction of $434,400.00. Following the completion of the transaction, the president owned 2,072,899 shares of the company's stock, valued at $30,015,577.52. This represents a 1.43% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the company's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $15.28, for a total transaction of $259,760,000.00. Following the transaction, the director directly owned 44,302,175 shares of the company's stock, valued at approximately $676,937,234. This represents a 27.73% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,685,262 shares of company stock worth $269,685,496. 7.00% of the stock is owned by insiders.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock traded up $0.06 on Wednesday, hitting $12.40. The company's stock had a trading volume of 2,489,982 shares, compared to its average volume of 2,269,998. Alignment Healthcare, Inc. has a 52-week low of $7.92 and a 52-week high of $21.06. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 2.95. The firm has a fifty day moving average price of $14.29 and a 200-day moving average price of $15.32. The company has a market capitalization of $2.45 billion, a P/E ratio of -25.83 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. The company had revenue of $926.93 million for the quarter, compared to analyst estimates of $889.83 million. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. The firm's quarterly revenue was up 47.5% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.25) EPS. On average, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Robert W. Baird boosted their target price on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. UBS Group boosted their target price on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Finally, Stifel Nicolaus boosted their target price on shares of Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research report on Tuesday, April 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $17.17.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.